Pages that link to "Q50589472"
Jump to navigation
Jump to search
The following pages link to Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China (Q50589472):
Displaying 50 items.
- Screening for nasopharyngeal cancer (Q24187937) (← links)
- Screening for nasopharyngeal carcinoma (Q24239852) (← links)
- Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature (Q27021572) (← links)
- Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for fie (Q33239049) (← links)
- The prevalence and prevention of nasopharyngeal carcinoma in China (Q33579447) (← links)
- Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan (Q33847952) (← links)
- Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138. (Q33973347) (← links)
- Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China (Q34081186) (← links)
- Viral hit and run-oncogenesis: Genetic and epigenetic scenarios (Q34135741) (← links)
- Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia. (Q34202451) (← links)
- Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine (Q34254852) (← links)
- Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma (Q34483687) (← links)
- A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). (Q34550781) (← links)
- Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up (Q34841962) (← links)
- Early Detection of Nasopharyngeal Carcinoma (Q35055640) (← links)
- Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China (Q35521697) (← links)
- Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review. (Q35824288) (← links)
- Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma (Q35963843) (← links)
- The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers (Q36027817) (← links)
- The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove (Q36433849) (← links)
- Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility (Q36474978) (← links)
- Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening. (Q36539838) (← links)
- Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population (Q37080931) (← links)
- Subtype distribution and long-term titer fluctuation patterns of serum anti-Epstein-Barr virus antibodies in a non-nasopharyngeal carcinoma population from an endemic area in South China: a cohort study (Q37178265) (← links)
- Detection of epstein-barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography (Q38556187) (← links)
- EBV-Specific Immune Response: Early Research and Personal Reminiscences (Q38596333) (← links)
- Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis (Q38694375) (← links)
- Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum. (Q39396128) (← links)
- Benign and Malignant Disease Caused by EBV (Q40143088) (← links)
- Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum (Q41130447) (← links)
- Vaccination against Epstein-Barr virus: current progress and future strategies (Q41350801) (← links)
- Human genetic variants of homologous recombination repair genes first found to be associated with Epstein-Barr virus antibody titers in healthy Cantonese (Q43871340) (← links)
- Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China. (Q44562504) (← links)
- Interval cancers in nasopharyngeal carcinoma screening: comparing two screening intervals after a negative initial screening result (Q44599305) (← links)
- Elevated Epstein–Barr virus seroreactivity among unaffected members of families with nasopharyngeal carcinoma (Q45364179) (← links)
- Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma (Q45762051) (← links)
- Detection of IgA antibodies to Epstein-Barr virus-associated antigens by ELISA (Q45796006) (← links)
- Epstein-barr virus-specific serodiagnostic tests in carcinomas of the head and neck (Q45797977) (← links)
- Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma (Q45881000) (← links)
- Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population. (Q47106227) (← links)
- Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong (Q51137004) (← links)
- An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models. (Q51154383) (← links)
- An efficacy analysis for nasopharyngeal carcinoma screening of different screening intervals (Q51184991) (← links)
- Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma. (Q52685801) (← links)
- Nasopharyngeal carcinoma: A review of current updates. (Q54252954) (← links)
- The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma. (Q54254993) (← links)
- Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum (Q57262055) (← links)
- [Migration and cancer] (Q69545454) (← links)
- Presence of EBV-DNA sequences in nasopharyngeal cells of individuals without IgA-VCA antibodies (Q70175546) (← links)
- Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization (Q92755996) (← links)